You are here

Article Text

Article menu
Download PDFPDF
Clinical prediction guide
A clinical prediction model predicted absence of significant fibrosis in chronic hepatitis B

https://doi.org/10.1136/ebm.10.5.155

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Hui AY, Chan HL, Wong VW, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616–23.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 Q In patients with chronic hepatitis B, what clinical and laboratory variables predict liver fibrosis?

    Clinical impact ratings Internal medicine ★★★★★★☆ Gastroenterology ★★★★★★☆

    METHODS

    Embedded ImageDesign:

    cohort study with independent derivation and validation sets.

    Embedded ImageSetting:

    Prince of Wales Hospital, Hong Kong.

    Embedded ImagePatients:

    235 patients (mean age 39 y, 77% men) who had HBV-DNA concentrations >105 copies/ml and were treatment-naïve. Alanine transaminase (ALT) concentrations were 1.5–10 × the upper limit of normal; ALT concentrations were not part of the inclusion criteria for cirrhotic patients. 150 patients formed the derivation set, and 85 patients formed the validation set.

    Embedded ImageDescription of prediction guide:

    predictive models were developed by using univariate analysis to obtain significant variables; these were entered in a multivariate stepwise logistic regression. The diagnostic value of each …

    View Full Text